EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Adiuvo Investments's Enterprise Value is zł33.29 Mil.
Adiuvo Investments's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was zł-0.33 Mil. Therefore, Adiuvo Investments's EV-to-FCF for today is -99.68.
The historical rank and industry rank for Adiuvo Investments's EV-to-FCF or its related term are showing as below:
WAR:ADV'
s EV-to-FCF Range Over the Past 10 Years
Min: -422.95 Med: -6.82 Max: 38.73
Current: -99.68
During the past 13 years, the highest EV-to-FCF of Adiuvo Investments was 38.73. The lowest was -422.95. And the median was -6.82.
WAR:ADV's EV-to-FCF is ranked worse than 100% of 417
companies
in the Medical Devices & Instruments industry
Industry Median: 23.54
vs WAR:ADV: -99.68
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Adiuvo Investments's PE Ratio (TTM) for today is calculated as:
Adiuvo Investments's share price for today is zł0.444.
Adiuvo Investments's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.320.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Adiuvo Investments EV-to-FCF Related Terms
Adiuvo Investments EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Adiuvo Investments's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Adiuvo Investments's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adiuvo Investments EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adiuvo Investments's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Adiuvo Investments's EV-to-FCF falls into.
Adiuvo Investments's current Enterprise Value is zł33.29 Mil.
Adiuvo Investments's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.33 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adiuvo Investments (WAR:ADV) has a EV-to-FCF of -99.68 as of Jul. 06, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Adiuvo Investments and its competitors. According to the industry distribution chart, Adiuvo Investments ranks #999999 out of 417 companies in the Medical Devices & Instruments industry.
Is Adiuvo Investments' EV-to-FCF too high?
Adiuvo Investments' current EV-to-FCF is -99.68. Based on the distribution chart, Adiuvo Investments ranks #999999 out of 417 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Adiuvo Investments has a GF Score™ of 28/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Adiuvo Investments' EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Adiuvo Investments ranks #999999 out of 417 companies for EV-to-FCF. This places Adiuvo Investments in the lower half of its industry. The industry median EV-to-FCF is 23.54. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.54, based on 417 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Adiuvo Investments and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adiuvo Investments's current EV-to-FCF is -99.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adiuvo Investments stock overvalued right now?
Based on GuruFocus' analysis, Adiuvo Investments (WAR:ADV) is currently considered Fairly Valued. The stock's GF Value™ is zł0.46, compared to a current price of zł0.44 — trading 3.5% below its estimated fair value. The current EV-to-FCF is -99.68. Adiuvo Investments' overall GF Score™ is 28/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Adiuvo Investments (WAR:ADV), the current EV-to-FCF is -99.68 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adiuvo Investments (WAR:ADV) Overvalued in 2026?
Based on GuruFocus' analysis, Adiuvo Investments stock appears to be undervalued.
The current stock price of zł0.44 is trading 3.5% below its estimated GF Value™ of zł0.46.
GuruFocus considers Adiuvo Investments to be Fairly Valued.
Key valuation signals for WAR:ADV:
EV-to-FCF: -99.68
GF Value™: zł0.46 vs. price of zł0.44 (3.5% below fair value)
No single metric tells the full story. See the WAR:ADV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adiuvo Investments SA is engaged in the selection, development, financing and commercialization of projects in the international market. The new technologies developed by the company focus on disease management, monitoring healthy lifestyle and treatment with the help of mobile devices and supplementation and functional food, or food, which in addition to nutritional properties also has health properties.
28GF Score
Get the complete analysis for WAR:ADV
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:ADV has been successfully added to your 
